NewGenIvf Group Limited (NIVF) stock forecast & analysis
0.1680
NasdaqCM · USD
Up: +0.0960, +133.3%
1 analysis
- Open
- 0.1658
- Previous close
- 0.0720
- Day range
- 0.1473 – 0.2575
- 52-week range
- 0.0640 – 1,539.00
- Volume (shares)
- 847.69M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 2.78M
- P/E ratio
- 0.00
- Dividend yield
- Not available
- Beta
- -0.04
- Market cap
- 468.66K
Market Scanner’s AI analysis of NewGenIvf Group Limited (NIVF), updated October 2026: NIVF's recent analyses covered significant price declines, oversold technical indicators, and a notable debt-to-cash ratio.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of NewGenIvf Group Limited (NIVF) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
NIVF's recent analyses covered significant price declines, oversold technical indicators, and a notable debt-to-cash ratio.
Recent analyses for NIVF tracked a sharp 7-day and 30-day price decline, pushing the stock significantly below its 50-day and 200-day moving averages. The stock is trading in oversold territory according to RSI and Bollinger Bands, though the MFI suggests strong buying pressure. The company's fundamentals show a high profit margin and return on equity, but also a substantial total debt relative to its cash reserves.
NIVF news & sentiment
News reports highlighted a significant worker shortage in the semiconductor industry and the upcoming launch of a new product, NovaJet. Social media discussion and news sentiment regarding NIVF itself were not covered in the provided notes.
NIVF technical picture
NIVF's price action showed a strong downward trend, trading significantly below its 50-day and 200-day moving averages. Momentum indicators were mixed, with bearish signals from the MACD but oversold conditions indicated by the RSI and Bollinger Bands, while the MFI suggested strong buying pressure.
Fundamentals
The company demonstrated strong revenue growth and high profit margins, alongside a robust return on equity. However, its total debt significantly outweighed its available cash reserves.
Factors discussed — upside
- Strong buying pressure indicated by MFI
- Oversold RSI and trading below lower Bollinger Band
- High profit margin and return on equity
Factors discussed — risks
- Significant 7-day and 30-day price declines
- Price trading well below 50-day and 200-day SMAs
- Total debt exceeds total cash reserves
- Technical indicators
- Price trends
- Company fundamentals
- Debt and cash position
Summary updated .
NIVF technical indicators
Common technical indicators for NIVF, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 1.52 | Price below |
| 10-day exponential moving average | 0.49 | Price below |
| Relative strength index (14-day) | 20.77 | Oversold |
| MACD line (12/26/9) | -0.3972 | Below its signal line |
| Bollinger bands (20-day, 2σ) | 0.13 – 1.44 | Price inside the bands |
Analyses
Recent NIVF.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for NewGenIvf Group Limited?
- The bull case for NIVF centers on strong buying pressure indicated by the Money Flow Index, alongside oversold conditions on the RSI and Bollinger Bands. The company's fundamentals also present a positive picture with a high profit margin and return on equity.
- What are the risks for NewGenIvf Group Limited?
- Risks for NIVF include significant price declines observed over the past 7 and 30 days, with the stock trading well below its key moving averages. Furthermore, the company's total debt exceeds its available cash reserves.
- Is NewGenIvf Group Limited bullish or bearish?
- Recent AI analyses of NewGenIvf Group Limited examined factors on both sides. Discussed upside: The bull case for NIVF centers on strong buying pressure indicated by the Money Flow Index, alongside oversold conditions on the RSI and Bollinger Bands. The company's fundamentals also present a positive picture with a high profit margin and return on equity. Discussed risks: Risks for NIVF include significant price declines observed over the past 7 and 30 days, with the stock trading well below its key moving averages. Furthermore, the company's total debt exceeds its available cash reserves. These are descriptive observations, not a recommendation.
- What is the latest sentiment on NewGenIvf Group Limited?
- News reports highlighted a significant worker shortage in the semiconductor industry and the upcoming launch of a new product, NovaJet. Social media discussion and news sentiment regarding NIVF itself were not covered in the provided notes.
- How does Market Scanner analyse NewGenIvf Group Limited?
- Every analysis of NewGenIvf Group Limited runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
- Bundles used
- gemini-low-v2
Run a fresh NIVF.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.